|apersy|

Value | Commercial | Access

….What we were reading in March….

  • Funding weight-loss treatments
  • AI regulation and access pathways in the UK: New developers resources
  • Medical cannabis prescribing clarified in Germany
  • The ‘Not cost-effective at zero price’ conundrum
  • NICE’s new proportionate approach to health technology evaluation

Other recent posts: